🇺🇸 FDA
Patent

US 11319330

Tricyclic furan-substituted piperidinedione compound

granted A61KA61K31/4525A61K31/453

Quick answer

US patent 11319330 (Tricyclic furan-substituted piperidinedione compound) held by Medshine Discovery Inc. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4525, A61K31/453, A61K31/454, A61K31/4545